Last reviewed · How we verify
Lopramine (LOFEPRAMINE)
At a glance
| Generic name | LOFEPRAMINE |
|---|---|
| Drug class | Tricyclic Antidepressants |
| Target | Sodium-dependent noradrenaline transporter |
| Modality | Small molecule |
| Therapeutic area | Neuroscience |
| Phase | FDA-approved |
Approved indications
- Depressive disorder
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Lopramine CI brief — competitive landscape report
- Lopramine updates RSS · CI watch RSS